Efficacy and safety of Guiqihuoxue Capsules in the treatment of different types of cervical spondylosis: a prospective, single-centered, open-ended, randomized controlled study

INTERVENTION: 2:Guiqihuoxue capsule;1:; CONDITION: cervical spondylosis PRIMARY OUTCOME: NDI score;JOA score;mJOA score; INCLUSION CRITERIA: (1) Male or female aged 18 to 70 years; (2) From April 12, 2022 to October 11, 2023, patients were hospitalized in our department, and were diagnosed with cervical spondylosis after clinical manifestations combined with imaging examination; (3) Those who have not received other related treatments within 1 month before treatment; (4) Visual Analogue Scale (VAS) score is 3 to 8 points; (5) Patients who voluntarily joined this study, had correct understanding and good compliance, and carefully read and understood the informed consent form and signed it.